Treatment
Treatment A clinical trials
We’re tracking 8,306 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT01524211Recruiting
Stent grafts for treating aortic aneurysms and dissections
This trial studies a special stent-graft placed inside the aorta to treat aneurysms, penetrating ulcers, or chronic dissections. It aims to see how well these branch stent grafts fit and seal the problem area while reducing the need for open surgery.
Boca Raton, FloridaAges 18 years+ - NCT02107105Recruiting
Study how surgery affects life quality in rectal cancer
This trial studies how surgical treatment for rectal cancer affects patients’ quality of life and other day-to-day impacts. It may help doctors understand what to expect after surgery and how to better support patients.
Houston, TexasAges 18 years+ - NCT02042326RecruitingPhase 2
Sirolimus trial for severe arteriovenous malformations
This trial studies whether sirolimus (Rapamune®) can reduce problems from severe arteriovenous malformations (tangled blood vessel connections). It may help shrink the abnormal vessels or improve symptoms, by testing the medicine in people with certain AVM types.
BrusselsAges 2 years+ - NCT02040714Enrolling by invitation
Study of current treatments for Perthes hip disease
This study follows children (and teens) with Legg-Calvé-Perthes disease to learn about how today’s treatments work in real life. It may help doctors choose the best next steps for your child’s hip health.
Birmingham, AlabamaAges 1–18 - NCT02029001RecruitingPhase 2
Personalized treatment matched to your tumor’s DNA changes
This Phase 2 study tests whether choosing cancer drugs based on specific DNA or blood test results from your tumor can work better for people with advanced solid tumors. It aims to use a molecular tumor board’s recommendation to guide the safest, most likely targeted treatment for each patient.
BordeauxAges 18 years+ - NCT02081768RecruitingPhase 3
Yttrium radiation liquid for cyst-like brain tumors near the pituitary
This Phase 3 trial studies a radioactive liquid called yttrium colloid (90Y) given around the time of surgery for cyst-like tumors near the pituitary gland. The goal is to see if it can improve treatment when you need an operation.
Halifax, Nova ScotiaAges 17 years+ - NCT01341327Recruiting
Study of treatment choices for left main artery narrowing
This observational study looks at people with a significantly narrowed “left main” heart artery and records treatment decisions and follow-up outcomes. It may help doctors better understand which care approaches work best for this condition in real-world practice.
ShanghaiAges 18 years+ - NCT01881503Enrolling by invitation
Hemopure for life-threatening anemia when blood transfusions aren’t an option
This study offers HBOC-201 (Hemopure), a type of blood substitute made from bovine (beef) hemoglobin, to treat severe, life-threatening anemia. It’s meant for adults who have very low hemoglobin with serious signs of poor oxygen delivery, and who can’t (or don’t qualify) for standard blood transfusions.
Englewood, New JerseyAges 18–80 - NCT02081755Enrolling by invitationPhase 4
Everolimus after liver transplant to lower liver cancer return
This trial studies whether everolimus, a transplant medicine, can safely reduce the chance that liver cancer comes back after liver transplant. It compares how well the treatment works while carefully monitoring side effects and safety.
San Francisco, CaliforniaAges 18 years+ - NCT02122562RecruitingPhase 2
Ketamine treatment for depression that hasn’t responded to care
This Phase 2 study tests ketamine for people with major depression that hasn’t improved after at least one antidepressant. It aims to see whether ketamine can reduce depression symptoms during a current depressive episode.
Iowa City, IowaAges 18–55 - NCT01742143Recruiting
Helping underserved patients finish cancer treatment and feel better
This study tests a support program (ICCAN) designed to help people from underserved communities better complete chemotherapy or radiation and improve quality of life. It may help by connecting patients with practical resources and support during treatment.
Basking Ridge, New JerseyAges 21–80 - NCT00583817Enrolling by invitation
Endovascular repair for thoracic aortic aneurysms and dissections
This study tests whether repairing an enlarged or tearing (dissection) thoracic aorta using a catheter-based procedure can be safer for people who are high-risk for open surgery. It uses specialized stent grafts placed through blood vessels to seal the problem and prevent complications.
Boston, MassachusettsAges 18 years+ - NCT00730678Recruiting
Study genes to learn how treatment affects children
This study looks at genetic (DNA) differences to better understand why treatments work differently for children at St. Jude. It may help doctors choose safer or more effective treatments in the future.
Memphis, TennesseeAges Any age - NCT01269853RecruitingPhase 1/Phase 2
Bevacizumab directly into brain arteries for recurrent brain tumors
This early-stage trial tests whether giving a targeted cancer medicine (bevacizumab) directly into brain arteries can help shrink or control certain recurrent (coming back) brain tumors. It may be an option if standard treatments are no longer working.
New York, New YorkAges 18 years+ - NCT00001208Recruiting
Botulinum toxin for involuntary movement and muscle disorders
This study tests botulinum toxin (a medication that relaxes muscles) to treat various involuntary movements like tremors, muscle spasms, or uncontrolled facial movements. The goal is to see if this treatment can reduce your symptoms and improve your quality of life.
Bethesda, MarylandAges 2–100 - NCT00001645Recruiting
Evaluation and treatment of parasitic infections
This study evaluates and treats patients who may have a parasitic infection (an infection caused by parasites—tiny organisms that live in or on the body). Researchers will monitor your condition and provide care to help you get better.
Bethesda, MarylandAges 3 years+ - NCT00344188Recruiting
Study of Leishmania infections
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
Bethesda, MarylandAges 3–100 - NCT00060541Recruiting
Evaluation and treatment of brain and nerve surgery conditions
This is a research program at the National Institutes of Health that evaluates and treats people with surgical brain and nerve conditions—like brain tumors, epilepsy, Parkinson's disease, and chronic pain. You'll receive expert evaluation and care while helping doctors learn more about these disorders.
Bethesda, MarylandAges 4–99 - NCT01087333Recruiting
Share blood samples to help study blood cancers and treatments
This study collects human samples (like blood or other specimens) to learn more about hairy cell leukemia and other leukemias. It also helps researchers develop new lab-made immune-based medicines for cancer treatment.
Bethesda, MarylandAges 18 years+ - NCT00068003Enrolling by invitation
Harvesting Cancer Cells for Experimental Treatment
This trial collects immune cells from cancer patients or healthy volunteers to develop new experimental cancer treatments. Researchers will take a sample of your tumor or blood cells, grow them in the lab, and study how to use them to fight your cancer.
Bethesda, MarylandAges 18 years+ - NCT01273129Recruiting
Surgery for epilepsy that medicines cannot control
This trial looks at using brain surgery to treat epilepsy that does not improve with usual medicines, or epilepsy caused by a brain tumor. It may help some people reduce seizures if surgery is appropriate for their situation.
Bethesda, MarylandAges 8–99 - NCT00028080Recruiting
Evaluation and treatment for active Lyme disease
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
Bethesda, MarylandAges 2–99 - NCT00369421Recruiting
Diagnosis and care for inherited metabolic conditions
This trial helps evaluate people who may have an inherited (genetic) metabolic or related disorder, and sometimes includes treatment or guidance based on the diagnosis. It may involve blood and urine testing, and participation can include in-person visits or telehealth.
Bethesda, MarylandAges 1 month–115 years - NCT00001539Recruiting
Lyme disease study's treatment and recovery health
This study looks at the health of people who have had Lyme disease, including those with ongoing symptoms after treatment, and those who have recovered or never had it. It aims to understand the disease and find better ways to manage it.
Bethesda, MarylandAges 13–99
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,306 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.